Related Experiment Video
Updated: Sep 9, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Response of symptomatic myocardial ischemia in ischemic cardiomyopathy to intensive vasodilator therapy
T B Levine1, A B Levine, A Vincenzi
1Division of Cardiology, Henry Ford Hospital, Detroit, Michigan 48202, USA.
Insights
Angiotensin-converting enzyme inhibitors and nitrates significantly improve heart failure symptoms and reduce ischemia in patients with ischemic cardiomyopathy and angina. This vasodilator therapy offers cardiovascular protection by mitigating ischemia-related events.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Ischemic cardiomyopathy and ongoing angina pectoris present significant cardiovascular risks.
- Angiotensin-converting enzyme (ACE) inhibitors are known for their role in cardiovascular protection.
Purpose of the Study:
- To evaluate the cardiovascular protective effects of ACE inhibitors.
- To assess the response to intensive vasodilator therapy in patients with ischemic cardiomyopathy and active angina.
Main Methods:
- Patients with ischemic cardiomyopathy and ongoing angina pectoris received intensive vasodilator therapy.
- The therapy regimen included angiotensin-converting enzyme inhibition and nitrates.
Main Results:
- Intensive vasodilator therapy improved heart failure-related symptoms.
- Significant reduction in symptomatic ischemia was observed.
- Ischemia-related morbid events were significantly reduced.
Conclusions:
- Intensive vasodilator therapy with ACE inhibitors and nitrates provides cardiovascular protection.
- This therapeutic approach is effective in managing heart failure symptoms and reducing ischemia in affected patients.
Abstract:
To determine the cardiovascular protective effects of angiotensin-converting enzyme inhibitors, we examined the response to intensive vasodilator therapy in patients with ischemic cardiomyopathy and ongoing angina pectoris. We found that for patients with ischemic cardiomyopathy and ongoing active angina, intensive vasodilator therapy with angiotensin-converting enzyme inhibition and nitrates improved not only heart failure-related symptoms, but also resulted in a significant improvement in symptomatic ischemia and ischemia-related morbid events.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Myocarditis III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care